Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 232-263-4 | CAS number: 7803-62-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
There is one study (Omae et al., 1992, Reliability score 2) for repeated dose inhalation of silane (CAS 7803-62-5; EC No. 232-263-4) conducted using a protocol similar to OECD Test Guideline 412 (no information on GLP status) in male ICR mice. Following exposure for 6 hours/day, 5 days/week for four weeks to 1000 ppm silane, no adverse effects were recorded. Therefore, the NOAEC was considered to be ≥1000 ppm (≥1310 mg/m3). There are no oral or dermal repeated dose toxicity studies.
There is one study (Omae et al., 1992, Reliability score 2) for repeated dose inhalation of silane conducted using a protocol similar to OECD Test Guideline 412 (no information on GLP status) in male ICR mice. Following exposure for 6 hours/day, 5 day/week for four weeks to 1000 ppm silane, no adverse effects were recorded. Therefore, the NOAEC was considered to be ≥1000 ppm (≥1310 mg/m3). There are no oral or dermal repeated dose toxicity studies.
There is one study (Omae et al., 1992, Reliability score 2) for repeated dose inhalation of silane conducted using a protocol similar to OECD Test Guideline 412 (no information on GLP status) in male ICR mice. Following exposure for 6 hours/day, 5 day/week for four weeks to 1000 ppm silane, no adverse effects were recorded. Therefore, the NOAEC was considered to be ≥1000 ppm (≥1310 mg/m3). There are no oral or dermal repeated dose toxicity studies.
There is one study (Omae et al., 1992, Reliability score 2) for repeated dose inhalation of silane conducted using a protocol similar to OECD Test Guideline 412 (no information on GLP status) in male ICR mice. Following exposure for 6 hours/day, 5 day/week for four weeks to 1000 ppm silane, no adverse effects were recorded. Therefore, the NOAEC was considered to be ≥1000 ppm (≥1310 mg/m3). There are no oral or dermal repeated dose toxicity studies.
There is one study (Omae et al., 1992, Reliability score 2) for repeated dose inhalation of silane conducted using a protocol similar to OECD Test Guideline 412 (no information on GLP status) in male ICR mice. Following exposure for 6 hours/day, 5 day/week for four weeks to 1000 ppm silane, no adverse effects were recorded. Therefore, the NOAEC was considered to be ≥1000 ppm (≥1310 mg/m3). There are no oral or dermal repeated dose toxicity studies.
There is one study (Omae et al., 1992, Reliability score 2) for repeated dose inhalation of silane conducted using a protocol similar to OECD Test Guideline 412 (no information on GLP status) in male ICR mice. Following exposure for 6 hours/day, 5 day/week for four weeks to 1000 ppm silane, no adverse effects were recorded. Therefore, the NOAEC was considered to be ≥1000 ppm (≥1310 mg/m3). There are no oral or dermal repeated dose toxicity studies.
Key value for chemical safety assessment
Repeated dose toxicity: via oral route - systemic effects
Endpoint conclusion
- Endpoint conclusion:
- no study available
Repeated dose toxicity: inhalation - systemic effects
Link to relevant study records
- Endpoint:
- short-term repeated dose toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- No data
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
- Remarks:
- The study was well documented and meets generally accepted scientific principles, but there was no information on whether it was conducted in compliance with GLP.
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 412 (Subacute Inhalation Toxicity: 28-Day Study)
- Deviations:
- yes
- Remarks:
- Only males and one concentration used. No urinalysis. Food and water consumption not measured.
- GLP compliance:
- not specified
- Limit test:
- no
- Species:
- mouse
- Strain:
- ICR
- Details on species / strain selection:
- None specified
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Japan
- Age at study initiation: Five weeks
- Weight at study initiation: No data
- Fasting period before study: No data
- Housing: Five animals per transparent plastic cages with stainless steel wire-lined ceilings.
- Diet (e.g. ad libitum): Ad libitum
- Water (e.g. ad libitum): Ad libitum
- Acclimation period: One week
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22
- Humidity (%): 60
- Air changes (per hr): No data
- Photoperiod (hrs dark / hrs light): 12/12
IN-LIFE DATES: No data - Route of administration:
- inhalation
- Type of inhalation exposure:
- whole body
- Vehicle:
- other: unchanged (no vehicle)
- Details on inhalation exposure:
- GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
- Exposure apparatus: Animals were exposed in a tightly sealed 550 l stainless steel inhalation chamber with glass windows.
- Method of holding animals in test chamber: None
- Source and rate of air: filtered room air (no further details)
- Method of conditioning air: HEPA filter (no further details)
- Temperature, humidity, pressure in air chamber: No data
- Air flow rate: No data
- Air change rate: No data
- Treatment of exhaust air:
TEST ATMOSPHERE
- Brief description of analytical method used: Gas chromatography (no further details)
- Samples taken from breathing zone: no data - Analytical verification of doses or concentrations:
- yes
- Details on analytical verification of doses or concentrations:
- Silane concentrations were monitored at ten minute intervals using a gas chromatograph.
- Duration of treatment / exposure:
- 14 or 28 days
- Frequency of treatment:
- Six hours/day, five days/week
- Remarks:
- Doses / Concentrations:
1000 ppm
Basis:
nominal conc. - No. of animals per sex per dose:
- Ten males
- Control animals:
- yes
- Details on study design:
- - Dose selection rationale: 1) the concentration was 200 or 2000 times higher than the recommended TWA exposure limits by many countries, 2) sufficient to adversely affect the health of the mice, 3) the effect of oxygen deficiency on the mice would not need to be taken into account.
- Rationale for animal assignment (if not random): No data
- Rationale for selecting satellite groups: No satellite groups
- Post-exposure recovery period in satellite groups: No post-exposure recovery group
- Section schedule rationale (if not random): No data - Positive control:
- None
- Observations and examinations performed and frequency:
- CAGE SIDE OBSERVATIONS: Yes
- Time schedule: Daily
DETAILED CLINICAL OBSERVATIONS: No data
BODY WEIGHT: Yes
- Time schedule for examinations: Body weights were monitored for several days before exposure. The schedule during exposure was not reported.
FOOD CONSUMPTION:
- Food consumption for each animal determined and mean daily diet consumption calculated as g food/kg body weight/day: No
FOOD EFFICIENCY:
- Body weight gain in kg/food consumption in kg per unit time X 100 calculated as time-weighted averages from the consumption and body weight gain data: No
WATER CONSUMPTION: No
OPHTHALMOSCOPIC EXAMINATION: No
HAEMATOLOGY: Yes
- Time schedule for collection of blood: Assumed to be prior to sacrifice, but not stated in report.
- Anaesthetic used for blood collection: No data
- Animals fasted: No data
- How many animals: All
- Parameters checked in table 1 were examined.
CLINICAL CHEMISTRY: Yes
- Time schedule for collection of blood: Assumed to be prior to sacrifice, but not stated in report.
- Animals fasted: No data
- How many animals: All
- Parameters checked in table 1 were examined.
URINALYSIS: No
NEUROBEHAVIOURAL EXAMINATION: No - Sacrifice and pathology:
- GROSS PATHOLOGY: Yes (see table 2)
HISTOPATHOLOGY: Yes (see table 2) - Statistics:
- No information.
- Clinical signs:
- effects observed, treatment-related
- Description (incidence and severity):
- Immediately after being exposed to silane on each day of exposure, most mice began to perform face washing movements and lick the lower abdomen for short periods.
- Mortality:
- mortality observed, treatment-related
- Description (incidence):
- There were no deaths.
- Body weight and weight changes:
- effects observed, treatment-related
- Description (incidence and severity):
- Average daily weight gains (ADWG) from Monday morning to Friday morning (four days exposure) were always smaller in exposed than nonexposed mice, but were not statistically significant. ADWG from Friday morning to Monday morning (one day of exposure and two days nonexposure), was greater in exposed than nonexposed mice (statistically significant in 3/4 week) (see Table 3).
- Food consumption and compound intake (if feeding study):
- not examined
- Food efficiency:
- not examined
- Water consumption and compound intake (if drinking water study):
- not examined
- Ophthalmological findings:
- not examined
- Haematological findings:
- effects observed, treatment-related
- Description (incidence and severity):
- White blood cell counts, lymphocytes, and nonsegmented neutrophils were increased significantly in animals exposed for four weeks (see Table 4).
- Clinical biochemistry findings:
- no effects observed
- Urinalysis findings:
- not examined
- Behaviour (functional findings):
- not examined
- Organ weight findings including organ / body weight ratios:
- no effects observed
- Description (incidence and severity):
- There were no effects on organ weights.
- Gross pathological findings:
- effects observed, treatment-related
- Description (incidence and severity):
- Mucous exudates and inflammatory and/or necrotic cells were observed in the nasal cavity more frequently in mice exposed for four weeks than in nonexposed mice, but the changes were mild.
- Histopathological findings: non-neoplastic:
- effects observed, treatment-related
- Histopathological findings: neoplastic:
- not examined
- Key result
- Dose descriptor:
- NOAEC
- Effect level:
- > 1 000 ppm
- Based on:
- test mat.
- Sex:
- male
- Basis for effect level:
- other: No significant adverse effects.
- Critical effects observed:
- not specified
- Conclusions:
- In a well conducted 14/28 day inhalation study (reliability score 2; no information on GLP status) conducted using a protocol similar to OECD 412, the NOAEL was greater than 1000 ppm (6 h/d, 5d/wk; the only concentration tested).
- Executive summary:
In a well conducted 14/28 day inhalation study (reliability score 2; no information on GLP status) conducted using a protocol similar to OECD Test Guideline 412, male ICR mice (n=10/group) were exposed to 1000 ppm silane for 6 hours/day, 5 days/week for 4 weeks. These treatments did not induce mortality. Mild irritation manifested in the form of a small amount of exudate in 8/10 animals and inflammation and/or necrosis of the cells of the nasal mucosa were observed in 6/10 animals. No histopathological changes were observed in the trachea, lung or cornea. Regarding haematology/biochemical parameters, there was a statistically significant increase in white blood cell (lymphocytes and neutrophils only) counts. The NOAEC was therefore greater than 1000 ppm.
Reference
Table 3 Average daily weight gain (Friday to Monday morning)
Week 1 -2 (n=20) | Week 2 -3 (n=10) | Week 3 -4 (n=10) | |
Exposed | 0.35 ± 0.26 | 0.44 ± 0.25 | 0.59 ± 0.17* |
Nonexposed | 0.46 ± 0.14 | 0.47 ± 0.14 | 0.27 ± 0.17 |
*p<0.01
Table 4 Summary of haemaology results.
Parameter | Nonexposed | Exposed |
Alkaline phosphatase | 56 ± 12 | 52.± 12 |
Aspartate aminotransferase | 69 ± 22 | 61 ± 14 |
Alanine aminotransferase | 19 ± 6 | 23 ± 10 |
Cholinesterase | 364 ± 96 | 376 ± 87 |
Blood urea nitrogen | 40 ± 5 | 35 ± 9 |
Sodium | 167 ± 3 | 168 ± 5 |
Potassium | 6.3 ± 1.4 | 7.1 ± 1.6 |
Red blood cell | 926 ± 46 | 951 ± 54 |
White blood cell | 25 ± 9 | 40 ± 14* |
Stab | 0.5 ± 0.2 | 1.1 ± 0.6* |
Steg | 5.2 ± 2.2 | 5.5 ± 1.9 |
Lymphocytes | 19.2 ± 8.2 | 32.9 ± 13.6* |
Monocytes | 0.1 ± 0.1 | 0.2 ± 0.3 |
*p<0.05
Taken from publication - no further details, such as units.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- NOAEC
- 1 310 mg/m³
- Study duration:
- subacute
- Species:
- mouse
Repeated dose toxicity: inhalation - local effects
Link to relevant study records
- Endpoint:
- short-term repeated dose toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- No data
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
- Remarks:
- The study was well documented and meets generally accepted scientific principles, but there was no information on whether it was conducted in compliance with GLP.
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 412 (Subacute Inhalation Toxicity: 28-Day Study)
- Deviations:
- yes
- Remarks:
- Only males and one concentration used. No urinalysis. Food and water consumption not measured.
- GLP compliance:
- not specified
- Limit test:
- no
- Species:
- mouse
- Strain:
- ICR
- Details on species / strain selection:
- None specified
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Japan
- Age at study initiation: Five weeks
- Weight at study initiation: No data
- Fasting period before study: No data
- Housing: Five animals per transparent plastic cages with stainless steel wire-lined ceilings.
- Diet (e.g. ad libitum): Ad libitum
- Water (e.g. ad libitum): Ad libitum
- Acclimation period: One week
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22
- Humidity (%): 60
- Air changes (per hr): No data
- Photoperiod (hrs dark / hrs light): 12/12
IN-LIFE DATES: No data - Route of administration:
- inhalation
- Type of inhalation exposure:
- whole body
- Vehicle:
- other: unchanged (no vehicle)
- Details on inhalation exposure:
- GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
- Exposure apparatus: Animals were exposed in a tightly sealed 550 l stainless steel inhalation chamber with glass windows.
- Method of holding animals in test chamber: None
- Source and rate of air: filtered room air (no further details)
- Method of conditioning air: HEPA filter (no further details)
- Temperature, humidity, pressure in air chamber: No data
- Air flow rate: No data
- Air change rate: No data
- Treatment of exhaust air:
TEST ATMOSPHERE
- Brief description of analytical method used: Gas chromatography (no further details)
- Samples taken from breathing zone: no data - Analytical verification of doses or concentrations:
- yes
- Details on analytical verification of doses or concentrations:
- Silane concentrations were monitored at ten minute intervals using a gas chromatograph.
- Duration of treatment / exposure:
- 14 or 28 days
- Frequency of treatment:
- Six hours/day, five days/week
- Remarks:
- Doses / Concentrations:
1000 ppm
Basis:
nominal conc. - No. of animals per sex per dose:
- Ten males
- Control animals:
- yes
- Details on study design:
- - Dose selection rationale: 1) the concentration was 200 or 2000 times higher than the recommended TWA exposure limits by many countries, 2) sufficient to adversely affect the health of the mice, 3) the effect of oxygen deficiency on the mice would not need to be taken into account.
- Rationale for animal assignment (if not random): No data
- Rationale for selecting satellite groups: No satellite groups
- Post-exposure recovery period in satellite groups: No post-exposure recovery group
- Section schedule rationale (if not random): No data - Positive control:
- None
- Observations and examinations performed and frequency:
- CAGE SIDE OBSERVATIONS: Yes
- Time schedule: Daily
DETAILED CLINICAL OBSERVATIONS: No data
BODY WEIGHT: Yes
- Time schedule for examinations: Body weights were monitored for several days before exposure. The schedule during exposure was not reported.
FOOD CONSUMPTION:
- Food consumption for each animal determined and mean daily diet consumption calculated as g food/kg body weight/day: No
FOOD EFFICIENCY:
- Body weight gain in kg/food consumption in kg per unit time X 100 calculated as time-weighted averages from the consumption and body weight gain data: No
WATER CONSUMPTION: No
OPHTHALMOSCOPIC EXAMINATION: No
HAEMATOLOGY: Yes
- Time schedule for collection of blood: Assumed to be prior to sacrifice, but not stated in report.
- Anaesthetic used for blood collection: No data
- Animals fasted: No data
- How many animals: All
- Parameters checked in table 1 were examined.
CLINICAL CHEMISTRY: Yes
- Time schedule for collection of blood: Assumed to be prior to sacrifice, but not stated in report.
- Animals fasted: No data
- How many animals: All
- Parameters checked in table 1 were examined.
URINALYSIS: No
NEUROBEHAVIOURAL EXAMINATION: No - Sacrifice and pathology:
- GROSS PATHOLOGY: Yes (see table 2)
HISTOPATHOLOGY: Yes (see table 2) - Statistics:
- No information.
- Clinical signs:
- effects observed, treatment-related
- Description (incidence and severity):
- Immediately after being exposed to silane on each day of exposure, most mice began to perform face washing movements and lick the lower abdomen for short periods.
- Mortality:
- mortality observed, treatment-related
- Description (incidence):
- There were no deaths.
- Body weight and weight changes:
- effects observed, treatment-related
- Description (incidence and severity):
- Average daily weight gains (ADWG) from Monday morning to Friday morning (four days exposure) were always smaller in exposed than nonexposed mice, but were not statistically significant. ADWG from Friday morning to Monday morning (one day of exposure and two days nonexposure), was greater in exposed than nonexposed mice (statistically significant in 3/4 week) (see Table 3).
- Food consumption and compound intake (if feeding study):
- not examined
- Food efficiency:
- not examined
- Water consumption and compound intake (if drinking water study):
- not examined
- Ophthalmological findings:
- not examined
- Haematological findings:
- effects observed, treatment-related
- Description (incidence and severity):
- White blood cell counts, lymphocytes, and nonsegmented neutrophils were increased significantly in animals exposed for four weeks (see Table 4).
- Clinical biochemistry findings:
- no effects observed
- Urinalysis findings:
- not examined
- Behaviour (functional findings):
- not examined
- Organ weight findings including organ / body weight ratios:
- no effects observed
- Description (incidence and severity):
- There were no effects on organ weights.
- Gross pathological findings:
- effects observed, treatment-related
- Description (incidence and severity):
- Mucous exudates and inflammatory and/or necrotic cells were observed in the nasal cavity more frequently in mice exposed for four weeks than in nonexposed mice, but the changes were mild.
- Histopathological findings: non-neoplastic:
- effects observed, treatment-related
- Histopathological findings: neoplastic:
- not examined
- Key result
- Dose descriptor:
- NOAEC
- Effect level:
- > 1 000 ppm
- Based on:
- test mat.
- Sex:
- male
- Basis for effect level:
- other: No significant adverse effects.
- Critical effects observed:
- not specified
- Conclusions:
- In a well conducted 14/28 day inhalation study (reliability score 2; no information on GLP status) conducted using a protocol similar to OECD 412, the NOAEL was greater than 1000 ppm (6 h/d, 5d/wk; the only concentration tested).
- Executive summary:
In a well conducted 14/28 day inhalation study (reliability score 2; no information on GLP status) conducted using a protocol similar to OECD Test Guideline 412, male ICR mice (n=10/group) were exposed to 1000 ppm silane for 6 hours/day, 5 days/week for 4 weeks. These treatments did not induce mortality. Mild irritation manifested in the form of a small amount of exudate in 8/10 animals and inflammation and/or necrosis of the cells of the nasal mucosa were observed in 6/10 animals. No histopathological changes were observed in the trachea, lung or cornea. Regarding haematology/biochemical parameters, there was a statistically significant increase in white blood cell (lymphocytes and neutrophils only) counts. The NOAEC was therefore greater than 1000 ppm.
Reference
Table 3 Average daily weight gain (Friday to Monday morning)
Week 1 -2 (n=20) | Week 2 -3 (n=10) | Week 3 -4 (n=10) | |
Exposed | 0.35 ± 0.26 | 0.44 ± 0.25 | 0.59 ± 0.17* |
Nonexposed | 0.46 ± 0.14 | 0.47 ± 0.14 | 0.27 ± 0.17 |
*p<0.01
Table 4 Summary of haemaology results.
Parameter | Nonexposed | Exposed |
Alkaline phosphatase | 56 ± 12 | 52.± 12 |
Aspartate aminotransferase | 69 ± 22 | 61 ± 14 |
Alanine aminotransferase | 19 ± 6 | 23 ± 10 |
Cholinesterase | 364 ± 96 | 376 ± 87 |
Blood urea nitrogen | 40 ± 5 | 35 ± 9 |
Sodium | 167 ± 3 | 168 ± 5 |
Potassium | 6.3 ± 1.4 | 7.1 ± 1.6 |
Red blood cell | 926 ± 46 | 951 ± 54 |
White blood cell | 25 ± 9 | 40 ± 14* |
Stab | 0.5 ± 0.2 | 1.1 ± 0.6* |
Steg | 5.2 ± 2.2 | 5.5 ± 1.9 |
Lymphocytes | 19.2 ± 8.2 | 32.9 ± 13.6* |
Monocytes | 0.1 ± 0.1 | 0.2 ± 0.3 |
*p<0.05
Taken from publication - no further details, such as units.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- NOAEC
- 1 310 mg/m³
- Study duration:
- subacute
- Species:
- mouse
Repeated dose toxicity: dermal - systemic effects
Endpoint conclusion
- Endpoint conclusion:
- no study available
Repeated dose toxicity: dermal - local effects
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
There is one repeated dose
toxicity study (Omae et al., 1992, reliability score 2) available
for the inhalation of silane. In
this study, which was similar to OECD Test Guideline 412, groups of 10
male ICR mice were exposed to 1000 ppm silane for 6 hours/day, 5
days/week for four weeks. These treatments did not induce mortality.
Mild irritation manifested in the form of a small amount of exudate in
8/10 animals and inflammation and/or necrosis of cells of the nasal
mucosa were observed in
6/10 animals. No histopathological changes were observed in the trachea,
lung or cornea. There was also a statistically significant increase in
white blood cell (lymphocytes and neutrophils only) counts.
None of these changes were considered to be adverse and therefore the
No-Observed-Adverse-Effect-Concentration (NOAEC) was ≥1000 ppm (1310 mg/m3).
There are no oral or dermal repeated dose toxicity studies.
Justification for classification or non-classification
Based on the available repeated dose toxicity data silane does not require classification for Specific Target Organ Toxicity following repeat exposure (STOT RE) according to Regulation (EC) 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.